Apellis Pharmaceuticals Inc APLS announced that the Phase 2 MERIDIAN study evaluating systemic Pegcetacoplan in amyotrophic lateral sclerosis (ALS) did not meet its primary
Clene Inc CLNN announced new results shows obtained ALS Patient Function Score (ALSFRS-R) and Delayed Time to Clinical Worsening from the most recent 12-month data
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents